NIH Turned Down Investigators Who Provoked Ire From Alcohol Industry

An email exchange and an unusual meeting suggest a connection between an institute’s pursuit of industry support and the rejection of a grant application.

Written byShawna Williams
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, KATARZYNABIALASIEWICZA research funding request to the National Institutes of Health (NIH) may have been quashed as part of an effort to woo industry sponsors of another large study, reports STAT News. The evidence includes an email exchange between the director of the National Institute of Alcohol Abuse and Alcoholism (NIAAA) and an alcohol company executive pledging not to fund the type of study that linked alcohol advertising to teen drinking.

The news report builds on earlier revelations by Wired and The New York Times that NIAAA scientists courted industry funders of a study on the health effects of moderate alcohol consumption by emphasizing the probability that the results would favor such consumption. STAT adds fresh evidence that conflicts of interest may have influenced decisions at the National Institutes of Health (NIH), the largest federal funder of biomedical research.

In the article published by STAT yesterday (April 2), Michael Siegel, a community health researcher at Boston University School of Public Health, gives an account of a 2015 meeting in which he and a coinvestigator on an NIAAA-funded study were summoned to the institute to discuss the work. In the meeting, George Koob, the NIAAA Director, “kept ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies